Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check11 days agoChange DetectedThe website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.SummaryDifference0.0%
- Check18 days agoChange DetectedThe website has updated the contact details section for the study, now providing clearer information on who to contact for questions and where the study is taking place, reflecting a revision from v2.12.2 to v2.13.0.SummaryDifference1%
- Check26 days agoChange DetectedSeveral key resources related to idiopathic pulmonary fibrosis and other genetic conditions have been removed from the website, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference2%
- Check33 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added related to idiopathic pulmonary fibrosis and various health organizations, while the previous version 2.12.1 has been removed.SummaryDifference2%
- Check47 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.